GUJARAT THEMIS BIOSYN
Back to Balance Sheet
|
GUJARAT THEMIS BIOSYN Last 5 Year Total Non-Current Liabilities History
[Standalone]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Total Non-Current Liabilities | ₹32 Cr | ₹3.58 Cr | ₹1.90 Cr | ₹2.02 Cr | ₹2.50 Cr |
What is the latest Total Non-Current Liabilities ratio of GUJARAT THEMIS BIOSYN ?
Year | Total Non-Current Liabilities |
---|---|
Mar2025 | ₹32 Cr |
Mar2024 | ₹3.58 Cr |
Mar2023 | ₹1.90 Cr |
Mar2022 | ₹2.02 Cr |
Mar2021 | ₹2.50 Cr |
How is Total Non-Current Liabilities of GUJARAT THEMIS BIOSYN Trending?
Years | Total Non-Current Liabilities | % Change | |
---|---|---|---|
Mar2025 | ₹32 Cr | 804.72 | |
Mar2024 | ₹3.58 Cr | 87.92 | |
Mar2023 | ₹1.90 Cr | -5.84 | |
Mar2022 | ₹2.02 Cr | -18.96 | |
Mar2021 | ₹2.50 Cr | - |
Compare Total Non-Current Liabilities of peers of GUJARAT THEMIS BIOSYN
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
GUJARAT THEMIS BIOSYN | ₹4,356.7 Cr | 10.4% | 7.3% | 13.5% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹394,187.0 Cr | 0.6% | -2.4% | -7% | Stock Analytics | |
DIVIS LABORATORIES | ₹163,282.0 Cr | -0.3% | -7.6% | 23% | Stock Analytics | |
CIPLA | ₹128,619.0 Cr | 1.8% | 8.1% | -0.1% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹124,712.0 Cr | 0.9% | 3.7% | 8.9% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹106,577.0 Cr | 1% | 2.4% | -9.6% | Stock Analytics |
GUJARAT THEMIS BIOSYN Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
GUJARAT THEMIS BIOSYN | 10.4% |
7.3% |
13.5% |
SENSEX | 0.9% |
-1.1% |
0.6% |
You may also like the below Video Courses